Fibrogen Inc (FGEN)

06:49 AM

FibroGen sells China biz to AstraZeneca for $160 M - BSA bureau

06:49 AM

Feb 21, 2025

FibroGen sells China unit to AstraZeneca for $160 million - MSN

Feb 21, 2025

Feb 21, 2025

AstraZeneca Secures China Rights to Anemia Drug, Buying FibroGen Unit in $160M Deal - MSN

Feb 21, 2025

Feb 21, 2025

Moody's Lifts AstraZeneca's Ratings, Revises Outlook to Stable -February 21, 2025 at 11:51 am EST - Marketscreener.com

Feb 21, 2025

Feb 21, 2025

FibroGen stock holds $10 target amid China unit sale By Investing.com - Investing.com South Africa

Feb 21, 2025

Feb 21, 2025

FibroGen stock holds $10 target amid China unit sale - Investing.com

Feb 21, 2025

Feb 21, 2025

There's No Escaping FibroGen, Inc.'s (NASDAQ:FGEN) Muted Revenues Despite A 46% Share Price Rise - Simply Wall St

Feb 21, 2025

Feb 21, 2025

StockNews.com Initiates Coverage on FibroGen (NASDAQ:FGEN) - MarketBeat

Feb 21, 2025

Feb 20, 2025

This Small Cap Soared Following Subsidiary Sale Announcement Worth $160M - The Globe and Mail

Feb 20, 2025

Feb 20, 2025

FibroGen to sell China business, extend cash runway to focus on cancer drugs - San Francisco Business Times

Feb 20, 2025

Feb 20, 2025

FibroGen sells China unit to AstraZeneca for $160m - Yahoo Finance

Feb 20, 2025

Feb 20, 2025

FibroGen (FGEN) to Release Earnings on Monday - MarketBeat

Feb 20, 2025

Feb 20, 2025

Amid Mounting Pressure In China, AstraZeneca Buys FibroGen's Chinese Unit For $160 Million - Benzinga

Feb 20, 2025

Feb 20, 2025

FibroGen sells China business to AstraZeneca - The Pharma Letter

Feb 20, 2025

Feb 20, 2025

AstraZeneca deepens China presence with FibroGen deal - BioPharma Dive

Feb 20, 2025

Feb 20, 2025

AstraZeneca to buy FibroGen's China unit for $160 million - MSN

Feb 20, 2025

Feb 20, 2025

FibroGen stock soars on China unit sale - Investing.com

Feb 20, 2025

Feb 20, 2025

FibroGen Sells Subsidiary to AstraZeneca for $160M - TipRanks

Feb 20, 2025

Feb 20, 2025

FibroGen soars on $160 mln China unit sale to AstraZeneca - TradingView

Feb 20, 2025

Feb 20, 2025

AstraZeneca to buy FibroGen's China unit for $160 million -February 20, 2025 at 07:04 am EST - Marketscreener.com

Feb 20, 2025

Feb 20, 2025

FibroGen Sells China Unit to AstraZeneca in $160 Million DealNews and Statistics - IndexBox, Inc.

Feb 20, 2025

Feb 20, 2025

FibroGen sells China unit to AstraZeneca in deal worth $160 million By Reuters - Investing.com

Feb 20, 2025

Feb 20, 2025

FibroGen sells China unit to AstraZeneca in deal worth $160 million -February 20, 2025 at 06:40 am EST - Marketscreener.com

Feb 20, 2025

Feb 20, 2025

FibroGen sells China unit to AstraZeneca for $160 million (FGEN:NASDAQ) - Seeking Alpha

Feb 20, 2025

Feb 20, 2025

FibroGen Announces Sale of China Subsidiary to AstraZeneca for Approximately $160 Million - Nasdaq

Feb 20, 2025

Feb 20, 2025

FibroGen sells China unit to AstraZeneca in deal worth $160 million - Yahoo Finance UK

Feb 20, 2025

Feb 20, 2025

FibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 Million - GlobeNewswire

Feb 20, 2025

Feb 20, 2025

Inside FibroGen's $160M China Exit: Strategic Pivot or Cash Grab? - StockTitan

Feb 20, 2025

Feb 19, 2025

Drug developers struggle in 2024; Fibrogen, Acadia, Atai post gains - BioWorld Online

Feb 19, 2025

Feb 18, 2025

FibroGen, Inc. (NASDAQ:FGEN) Short Interest Down 5.2% in January - Defense World

Feb 18, 2025

Feb 06, 2025

FibroGen Inc: Weathering Stock Market Storms with 51.09M Market Cap - The InvestChronicle

Feb 06, 2025

Feb 05, 2025

Trading Day Triumph: FibroGen Inc (FGEN) Ends at 0.46, a -2.61 Surge/Plunge - The Dwinnex

Feb 05, 2025

Feb 05, 2025

FibroGen (NASDAQ:FGEN) Earns Hold Rating from Analysts at StockNews.com - Defense World

Feb 05, 2025

Jan 28, 2025

JPMorgan Chase & Co. Has $668,000 Position in FibroGen, Inc. (NASDAQ:FGEN) - Defense World

Jan 28, 2025

Jan 26, 2025

Assenagon Asset Management S.A. Sells 415,812 Shares of FibroGen, Inc. (NASDAQ:FGEN) - Defense World

Jan 26, 2025

Jan 21, 2025

FibroGen (NASDAQ:FGEN) Share Price Passes Above 50-Day Moving AverageWhat's Next? - MarketBeat

Jan 21, 2025

Jan 15, 2025

FibroGen Inc (NASDAQ: FGEN) Is Down -5.77% – Can It Revive? - Stocks Register

Jan 15, 2025

Jan 13, 2025

FibroGen, Inc. (NASDAQ:FGEN) Shares Purchased by Geode Capital Management LLC - Defense World

Jan 13, 2025

Jan 06, 2025

Perspective Therapeutics Appoints FibroGen Veteran Juan Graham as New CFO to Drive Growth Strategy - StockTitan

Jan 06, 2025

Jan 05, 2025

State Street Corp Lowers Holdings in FibroGen, Inc. (NASDAQ:FGEN) - Defense World

Jan 05, 2025

Jan 02, 2025

Cue Biopharma (NASDAQ:CUE) versus FibroGen (NASDAQ:FGEN) Head-To-Head Comparison - Defense World

Jan 02, 2025

Jan 01, 2025

FibroGen (NASDAQ:FGEN) Coverage Initiated by Analysts at StockNews.com - Defense World

Jan 01, 2025

Jan 01, 2025

FibroGen (NASDAQ:FGEN) Coverage Initiated at StockNews.com - MarketBeat

Jan 01, 2025

Dec 31, 2024

Court of Chancery Applies Well-Settled Principles To Dismiss Malone/Caremark ‘Hybrid’ Claims - JD Supra

Dec 31, 2024

Dec 25, 2024

There's No Escaping FibroGen, Inc.'s (NASDAQ:FGEN) Muted Revenues Despite A 26% Share Price Rise - Simply Wall St

Dec 25, 2024

Dec 24, 2024

FibroGen (NASDAQ:FGEN) Now Covered by Analysts at StockNews.com - Defense World

Dec 24, 2024

Dec 24, 2024

Recent Investment Analysts’ Ratings Updates for FibroGen (FGEN) - Defense World

Dec 24, 2024

Dec 23, 2024

Fmr LLC Boosts Holdings in FibroGen, Inc. (NASDAQ:FGEN) - Defense World

Dec 23, 2024

Dec 20, 2024

HC Wainwright Comments on FibroGen FY2024 Earnings - Defense World

Dec 20, 2024

Dec 19, 2024

HC Wainwright Upgrades FibroGen (NASDAQ:FGEN) to Strong-Buy - Defense World

Dec 19, 2024

Dec 19, 2024

HC Wainwright Estimates FibroGen FY2026 Earnings - Defense World

Dec 19, 2024

Dec 18, 2024

FibroGen started at buy by H.C. Wainwright (FGEN:NASDAQ) - Seeking Alpha

Dec 18, 2024